AIBTOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

AIBOTICS, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026

$0.00+0.00 (+42.86%)

Close on Oct 19, 2026

Market cap: –
P/E (TTM): –
Dividend yield: –

AIBOTICS, INC. cash flow statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31
Stock-Based Compensation	–	0	0.00	1.02	4.31	0	0	–
Deferred Income Taxes	–	0	0	0	0	0	–	–
Change in Accounts Payable	0.73	0.34	0.16	0.23	0.41	0.00	0.05	0.00
Operating Cash Flow	-0.46	-0.26	-0.11	-0.66	-0.24	-0.01	0.10	-0.07
Capital Expenditures	–	–	–	0	0.00	0	–	–
Investing Cash Flow	–	–	0	0	0.00	0	0.00	0
Stock Issued	0.28	0	–	–	–	–	–	–
Financing Cash Flow	0.53	0.17	0	-0.23	1.40	0.13	–	–
Net Change in Cash	–	–	–	-0.88	1.16	0.11	0.10	-0.07
Free Cash Flow	–	–	–	-0.66	-0.24	-0.01	–	–
Income Taxes Paid	0	0	0	0	0	0	0	0.10
Interest Paid	0	0	0	0.02	0	0	0.00	0.00

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: 60.3%

Financial strength

Current ratio: 0.05
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 4.5%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –